IP Library Patent Application 18897927
Patent Application
App. No. 18/897,927

TRANSCATHETER DEVICE FOR TREATING TRICUSPID VALVE REGURGITATION

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/897,927
Abstract

A transcatheter device for treating the tricuspid valve regurgitation. The transcatheter device comprises a main shaft, a proximal portion, a distal tail, and a spacer body mounted on the main shaft and located between the proximal portion and the distal tail. This transcatheter device could be used for treating tricuspid valve regurgitation in a patient's heart. All or part of the transcatheter device is supported by the main shaft. The spacer body is mounted on the shaft, which travels through the spacer body. Also disclosed are a coaptation assembly that comprises the transcatheter device, and a method of treating tricuspid valve regurgitation using the transcatheter device.

Claims (18)

1 . A transcatheter device comprising:

a main shaft;

a proximal portion comprising a proximal segment of the main shaft and an intravascular anchor, wherein the proximal segment has a single bend;

a distal tail comprising a distal portion of the main shaft, wherein the distal tail has a C-shape configured to embrace a path along the pulmonary artery—the supraventricular crest of RV—the tricuspid valve—the right atrium and then toward IVC; and

a spacer body mounted on the main shaft and located between the proximal segment of the main shaft and the distal tail.

2 . The transcatheter device of claim 1 , wherein the spacer body has a non-linear shape.

3 . The transcatheter device of claim 1 , wherein the distal tail comprises a bend.

4 . The transcatheter device of claim 1 , wherein the distal tail comprises a proximal segment and a distal segment, wherein the distal segment has a thinner diameter than the proximal segment.

5 . The transcatheter device of claim 1 , wherein the spacer body has a length in the range of range of 4-13 cm.

6 . The transcatheter device of claim 1 , wherein the intravascular anchor is a spiral coil.

7 . The transcatheter device of claim 6 , wherein the intravascular anchor has at least two spirals.

8 . A coaptation assembly comprising:

a transcatheter device of claim 1 , wherein the main shaft comprises a lumen;

a guidewire traveling through the lumen of the main shaft;

a moveable delivery sheath that covers the spacer body and intravascular anchor;

a deployment catheter for intravascular deployment of the transcatheter device.

9 . The transcatheter device assembly of claim 8 , further comprising an entry opening on the main shaft at a location between the intravascular anchor and the spacer body and an exit opening on the main shaft at a tip of the distal tail;

wherein the lumen of the main shaft extends from the entry opening to the exit opening; wherein the guidewire travels through the lumen from the entry opening to the exit opening.

Assignments (2)
CHANGE OF NAME Recorded Sep 26, 2024
From: TAU CARDIO, INC.
To: TAU MEDICAL USA, INC.
Reel/Frame 069064/0330 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2024
From: KIM, JUNE HONG
To: TAU CARDIO INC.; TAU MEDICAL INC.
Reel/Frame 068711/0424 →